Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$3.81
-10.16%
Mkt Cap $432.15M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$11.00
Range $10.00 – $12.00
Implied Upside
+188.8%
Consensus $11.00 vs current $3.81
NASDAQ·Healthcare·Biotechnology
$3.81
-10.16%
Mkt Cap $432.15M
No recent rating data.
Price Target (7 analysts)
$11.00
Range $10.00 – $12.00
+188.8%
Consensus $11.00 vs current $3.81